Sign In
Skip to main content Open accessibility information page

Press Release

​​​​For Immediate Release:
January 23, 2018​

Office of The Attorney General
Gurbir S. Grewal, Attorney General

Division of Consumer Affairs
Sharon Joyce, Acting Director
 For Further Information Contact:
Sharon Lauchaire, 609-292-4791

Citizen Inquiries:
609-984-5828

​ ​ Proposed Regulation -
Prescription Monitoring Program:​ ​Gabapentin Reporting
​​

​ ​ ​

NEWARK – The Division of Consumer Affairs (Division) is proposing to amend the Prescription Monitoring Program (PMP) rules at N.J.A.C. 13:45A to require New Jersey licensed pharmacies and registered out-of-State pharmacies to electronically transmit information to the Division about prescriptions filled for gabapentin.

The proposed regulations, and information on how to submit a comment by March 3, 2018 can be viewed here.

Follow the Division of Consumer Affairs on its website.

Follow the New Jersey Attorney General’s Office online at Twitter, Facebook, Instagram & YouTube. The social media links provided are for reference only. The New Jersey Attorney General’s Office does not endorse any non-governmental websites, companies or applications.

###​
​​​
Last Modified: 1/25/2018 10:03 AM